Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Wednesday, April 16 2014 3:44am ET - U.S. Markets open in 5 hours and 46 minutes.
Industry Center
Industry Center > > Astellas Pharma Inc. Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Astellas Pharma Inc. Company Profile
Astellas Pharma is a shining star in the Japanese pharmaceuticals market. One of the largest prescription drug companies in Japan, the company's main products include organ transplant immunosuppressant Prograf, overactive bladder treatment Vesicare, hypertension therapy Micardis, prostate enlargement treatment Harnal, and cholesterol drug Lipitor (sold in Japan via an agreement with Pfizer). Astellas' products (including those under development) include cardiovascular, central nervous system, oncology, metabolic, infectious disease, inflammation/immunology, gastroenterology, and urology therapies. The company markets its products to health care professionals and consumers in global markets.
Headlines for Astellas Pharma Inc.
Astellas Named National Presenting Sponsor of the National Kidney Foundation Kidney Walk
- Tue 9:03 am ET
Medivation-Astellas Seek Xtandi Label Expansion
- Wed Mar 19
PharmAthene (PIP) Crumbles: Stock Falls by 7.1%
- Fri Apr 11
Tetraphase Slumps: TTPH Falls 10.3% in Session
- Tue 6:54 am ET
AVEO-Biodesix Ink Deal
- Fri Apr 11
AVEO Regains AV-203 Rights from Biogen
- Fri Mar 21
ARIAD Candidate in Phase II Study
- Wed Mar 26
Tokyo stocks close up 0.37%
- Wed Mar 26
Tokyo stocks up 0.23% by break
- Wed Mar 26
AstraZeneca's Forxiga Approved in Japan
- Tue Mar 25
Contact Information
Address: 2-3-11 Nihonbashi-Honcho, Chuo-ku
Tokyo 103-8411, Japan
Phone:+81-3-3244-3000
Fax:+81-3-3244-3272
Financial Highlights
Fiscal Year End:March
Revenue (2013):10669.50 M
Revenue Growth (1 yr):(-9.40%)
Employees (2013):17,454
Employee Growth (1 yr):2.20%
Key People
Chairman: Masafumi Nogimori
President and CEO: Yoshihiko Hatanaka
SVP and CFO: Yasumasa Masuda
Industry Information
Sector:
Industry:
Top Competitors
DAIICHI SANKYO COMPANY, LIMITED
Roche Holding Ltd
Takeda Pharmaceutical Company Limited
 


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?